Medical Research

18 year follow up study suggests high mortality risk from untreated sleep disordered breathing

Moderate-to-severe sleep apnea is independently associated with increased risk of mortality

Treatment of obstructive sleep apnea with CPAP may lower cardiovascular risk

CPAP treatment decreases auto accidents in sleep apnea sufferers


A study found 16% of Australian commercial drivers suffer from obstructive sleep apnea and 60% have sleep-disordered breathing.

Read more about sleep disordered breathing.

New Products

S8 AutoSet Spirit™ II
Latest APAP device. Featuring Easy-Breathe Technology™

Mirage Activa™ LT
Unequalled comfort

VPAP™ IV
Noninvasive bilevel pressure support. Compact, quiet and comfortable

Swift™ LT
Less is more.

VPAP™ III ST-A QuickNav
Large screen. Easier than ever

H4i™
Superior humidity output ... seamlessly integrated

News and Events

ResMed Inc. announces record financial results for the quarter ended September 30, 2008



News Release

ResMed supports IDF recommendations

International Diabetes Federation (IDF) makes statement supporting reciprocal screening of all patients with type 2 diabetes or sleep apnea.

Learn more about the link between OSA and type 2 diabetes.

Improving therapy

To get the most out of your treatment, read our FAQs.

Are you new to CPAP Therapy?



Are you new to continuous positive airway pressure (CPAP) therapy or an existing user?

Become a member of sleepVantage to access information, support and expert advice

ResMed is a leading developer, manufacturer, and marketer of products for the diagnosis and treatment of sleep-disordered breathing.

This page was last updated on: 7-11-2008